Meduslabs — Evidence-based health research
HomeCholesterolCholesterol: What It Is, HDL vs LDL, Levels, and How to Lower It
Key Takeaways

What is cholesterol, and why do we have it?

The body cannot function without cholesterol. It helps the body break down fats (lipids) in the small intestine so they can be absorbed into the bloodstream. In the liver, cholesterol combines with lipids and proteins to form complex compounds called lipoproteins. Cholesterol is essential for forming cell membranes, producing hormones, digesting food, and contributing to vitamin D production when the skin is exposed to sunlight. It allows human cells to move and change shape (which plants cannot do, because they have no cholesterol). Fundamentally, it is needed for the production and growth of new cells — which is why there is so much cholesterol in eggs.

Cholesterol and heart health

High cholesterol

So where does the problem of high cholesterol lie? Evidently, in too much production in the liver. A cholesterol level that is too high is associated with cardiovascular disease: atherosclerosis, stroke, heart attack, heart failure, pericarditis, coronary heart disease. Heart disease is the world's number-one killer (the second is cancer).26 The body has a mechanism to regulate the cholesterol balance: it produces so-called "good" cholesterol (HDL — high-density lipoprotein) which removes the "bad."

Are there two cholesterols? Good (HDL) and bad (LDL)?

Lowering cholesterol naturally

LDL cholesterol is the one called "bad." Why is it called bad, when it is one of the most important substances in the body — without it we would die? An excessive amount of this cholesterol is associated with coronary heart disease, heart attack, stroke and other circulatory and heart-related conditions. When the artery walls are damaged (we discuss why below), LDL cholesterol is sent to the site of damage as a "repair material." The problem arises when, because of unceasing inflammation, LDL becomes trapped inside the artery wall, oxidises, and together with immune cells forms plaques. This process, which narrows the arteries, is called atherosclerosis.

Cholesterol levels (norms)

At first glance, blood cholesterol figures can seem a little complicated. Cholesterol is measured in millimoles per litre of blood (sometimes mg/dl).

MeasureRangeMeaning
Total cholesterol< 5 mmol/lNormal
Total cholesterol5–6 mmol/lBorderline
Total cholesterol> 6 mmol/lToo high
LDL (lower is better)< 1.4 mmol/lTarget for people with heart disease or high risk
LDL< 1.8 mmol/lTarget for people with heart disease or attack risk
LDL< 3.0 mmol/lNormal
LDL> 5.0 mmol/lVery high
HDL (higher is better)< 1 mmol/l (men), < 1.2 mmol/l (women)Very poor

So where does TOO MUCH cholesterol come from?

The key question remains: why does your body produce too much cholesterol (we have already established that elevated cholesterol does not "come from" food, as you are usually led to believe)? "It's the genes!" your doctor may say; "Yes, it's DNA!" echo the big drug manufacturers. But do you really believe it is your grandmother's fault? Then where were the cholesterol problems, say, 300 years ago? Back then people consumed two or three times more calories per day, most of it from animal-source food. Genes do not change that fast, so a cholesterol "epidemic" (like the one now) would already have existed centuries ago. The cause lies elsewhere.

Cholesterol drugs (statins)

As mentioned, cholesterol is produced in the body. This synthesis is a complex process involving about 30 chemical reactions. The critical moment is when the enzyme HMG-CoA reductase produces mevalonate. This enzyme is especially significant because it controls whether cholesterol is produced or not. Because HMG-CoA reductase is the critical controller of cholesterol synthesis, statins intervene in this reaction and block it — and presto, cholesterol production is halted. But this does not address why the enzyme keeps receiving the signal to produce cholesterol in the first place.

Side effects of cholesterol drugs

Cholesterol medications and statins

The active ingredient in most cholesterol-lowering drugs prescribed to you is "statins." It is worth looking into their side effects — and the likelihood of them is considerable. And you would have to take them for life. Dr. Malcolm Kendrick argues that the drawbacks of statins outweigh the potential benefit for many people. Statin prescriptions rise by nearly 30% every year. Patients should ask their doctors: "How much longer will I live if I take statins — and what will the quality of that time be?"

What really drives high cholesterol

This may be entirely unexpected, but there is a great deal of research, and those who look can readily find the answers. So what drives excessive cholesterol production in your body? In short — sugar (glucose). How does this happen? It is known that cholesterol forms atherosclerotic plaques in the arteries and clogs blood vessels. But once you understand that cholesterol is a tool for controlling inflammation and managing the damage inflammation causes, the picture of the "system" becomes clear. The cause of chronic disease is inflammation, not cholesterol.20 The real culprit is inflammation — and what most inflames your blood vessels? Sugar causes enormous inflammation.

Lowering cholesterol

As mentioned, for many people taking cholesterol-lowering drugs (statins) can be dangerous. The best diet in that case is ketogenic. This diet is fairly hard to follow, because the proportions of all foods are the reverse of what we are used to. About 80% of all calories should come from fats (good fats, not heated oils or trans fats), about 15% from protein, and about 5% from carbohydrates — only from non-starchy vegetables (no starch). That means cauliflower, broccoli, courgette, cucumber and all leafy greens. So no porridge, no buns, no potatoes, bread, alcohol, fruit, flour or sugar.

How to maximally lower your cholesterol and improve your circulatory system without statins?

The answer is medicinal mushrooms. The first-generation statins were extracted from mushrooms and had no side effects. Do you know the biggest problem with medicinal mushrooms? They cannot be patented (the "patent" belongs to nature), so the big drug companies cannot monopolise markets and generate enormous cash flows. In Asia, medicinal mushrooms have been used for centuries, while in the Western hemisphere mushroom research has only been "catching up" in recent decades. Research scientifically supports the traditional use of medicinal mushrooms — and a precision formula combining several complementary cholesterol pathways is more effective than any single ingredient.

Related supplement

First-generation statins came from mushrooms. A precision formula combining several complementary cholesterol pathways is studied as more effective than any single ingredient.

AURI 25 by Zenius Labs™ →
What is the normal cholesterol level?

Total cholesterol below 5 mmol/l is normal, 5–6 mmol/l is borderline, and above 6 mmol/l is too high. For LDL, below 3.0 mmol/l is normal, while people with heart disease or high risk aim for below 1.4–1.8 mmol/l. HDL should be above 1 mmol/l (men) or 1.2 mmol/l (women).

Is dietary cholesterol the cause of high blood cholesterol?

Most cholesterol is produced in the liver, not obtained from food. The medix position is that excess production is driven largely by chronic inflammation — with sugar (glucose) a major inflammatory trigger — rather than by dietary cholesterol or genetics alone.

What is the difference between HDL and LDL cholesterol?

HDL (high-density lipoprotein) is the "good" cholesterol that removes excess from the body. LDL (low-density lipoprotein) is called "bad" because, amid chronic inflammation, it can become trapped in artery walls, oxidise, and form plaques (atherosclerosis). Both are essential to life.

Can cholesterol be lowered without statins?

A ketogenic diet and medicinal mushrooms are presented as approaches. The first-generation statins were themselves extracted from mushrooms. A precision formula combining several complementary cholesterol pathways, such as AURI 25 by Zenius Labs™, is studied as more effective than single ingredients. Always discuss any change with your doctor.

References
  1. Auricularia auricula — hypolipidemic properties. PubMed
  2. Polysaccharide-based cholesterol reduction mechanisms. PubMed
  3. Edible mushrooms — cardiovascular disease prevention. PubMed
  4. Beta-glucan dietary fiber and cholesterol. PubMed
  5. Medicinal mushrooms — cardiovascular review. PMC
  1. Auricularia polysaccharide — antithrombotic effects. PubMed
  2. Fungal polysaccharides — immunomodulatory activity. PubMed
  3. Auricularia auricula — hepatoprotective properties. PubMed
  4. Fungal polysaccharides — oxidative stress reduction. PubMed
  5. Dietary fiber and serum cholesterol reduction. PubMed
  6. Statin alternatives — natural compounds review. PubMed
  7. Plant sterols and cholesterol absorption. PubMed
  8. Mushroom extracts — lipid-lowering clinical evidence. PubMed
  9. Functional food compounds and dyslipidemia. PubMed
  10. Polysaccharide supplementation — metabolic outcomes. PubMed
  11. Dietary fiber — cardiovascular risk factors. PubMed
  12. Statin side effects — systematic review. PMC
  13. Auricularia polysaccharide structure and bioactivity. ScienceDirect
  14. Yuan Z et al. (1998) Hypoglycemic effect of A. auricula-judae. Biosci Biotechnol Biochem
  15. Yoona S-J et al. (2003) Anticoagulant polysaccharide from A. auricula. Thrombosis Research
  16. Francia C et al. (1999) Mushrooms and cardiovascular diseases. Int J Medicinal Mushrooms
  17. Auricularia auricula — antioxidant capacity. PubMed
  18. Medicinal mushrooms — therapeutic potential review. PubMed
  19. World Health Organization — cardiovascular disease statistics
  20. Natural lipid-lowering agents — clinical review. PMC
  21. Statin drug side effects — patient information. WebMD
  22. Netherlands RADAR survey — statin side effects. SpaceDoc
  23. American Diabetes Association
  24. Zhang Z et al. (2011) Auricularia polysaccharide prevents oxidative stress. Carbohydrate Polymers, 84(1), 638-648
  25. Chen Y et al. (2008) A. auricula polysaccharide — blood lipid metabolism. J Food Science, 73(6)
  26. Ikekawa T et al. (1968) Antitumor activity of edible mushroom extracts. Cancer Research, 29(3), 734-5
  27. Kho S et al. (2009) Antioxidant capacity of A. auricula-judae. J Medicinal Food, 12(1), 167-174
  28. Wu Z et al. (2010) A. auricula polysaccharides and heart enzymes. Int J Biol Macromolecules, 46(3), 284-288
  29. Luo G et al. (2009) Antioxidative properties of A. auricula and hawthorn. Innovative Food Science, 10(2), 215-221
  30. Glass CK, Witztum JL (2001) Atherosclerosis: The Road Ahead. Cell, 104(4), 503-516
  31. Giugliano D (2000) Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc Dis, 10(1), 38-44
  32. Shahidi F (2004) Functional foods: health promotion and disease prevention. J Food Science, 69(5), 146-149
  33. Misaki A et al. (1981) Antitumor polysaccharides from A. auricula-judae. Carbohydrate Research, 92(1), 115-29
  34. Barclay AW et al. (2008) Glycemic index and chronic disease risk. Am J Clin Nutr, 87, 627-37
  35. Boden G et al. (2005) Low-carbohydrate diet on appetite and blood glucose. Annals Internal Medicine, 142
  36. Brownlee M (2005) Pathology of diabetic complications. Diabetes, 1615-1625
  37. Djoussé L, Gaziano JM (2009) Dietary cholesterol and coronary artery disease. Atheroscler Rep, 11(6), 418-22
  38. Eaton SB et al. (1988) Stone agers in the fast lane. Am J Med, 84, 739-749
  39. Esposito K et al. (2002) Inflammatory cytokines and hyperglycemia. Circulation, 106, 2067-2072
  40. Greco TP et al. Oxidized-LDL complexes in acute coronary syndromes. Am J Clin Path, 133, 737-743
  41. Halton TL et al. (2006) Low carbohydrate diet and CVD in women. NEJM, 355, 1991-2002
  42. Jakobsen MU et al. (2010) Carbohydrates vs saturated fatty acids. Am J Clin Nutr, 91, 1764-8
  43. Mente A et al. (2009) Dietary factors and coronary heart disease. Arch Internal Medicine, 169(7), 659-69
  44. Siri-Tarino PW et al. (2010) Saturated fat, carbohydrate, and CVD. Am J Clin Nutr
  45. Welsh JA et al. (2010) Caloric sweetener and dyslipidemia. JAMA, 303(15), 1490-1497
  46. Westman EC et al. (2007) Low-carbohydrate nutrition and metabolism. Am J Clin Nutr, 86, 276-84
  47. Willett W (2011) The Great Fat Debate. J Am Diet Assoc, 111(5), 660-662
  48. Fan L et al. (2006) Auricularia Auricula Polysaccharide Flour. Food Chemistry, 101(3), 1158-1163
  49. Kaliora AC et al. (2006) Dietary Antioxidant in Preventing Atherogenesis. Atherosclerosis, 187(1), 1-17
  50. Chen Y et al. (2010) Hypocholesterolemic Effects of Auricularia Auricula Ethanol Extract
  51. Yoon SJ et al. The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin. Thrombosis research. 2003. PubMed
  52. Bian C et al. A Novel Polysaccharide from AuriculariaAuricula Alleviates Thrombosis Induced by Carrageenan in Mice. Molecules (Basel, Switzerland). 2022. PubMed
  53. Shi Q et al. Isolation, Characterization, and Antioxidant Activity of Melanin from Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2023. PubMed
  54. Yin CM et al. Physicochemical Properties and Antioxidant Activity of Natural Melanin Extracted from the Wild Wood Ear Mushroom, Auricularia auricula (Agaricomycetes). International journal of medicinal mushrooms. 2022. PubMed
  55. Liu X et al. Comprehensive utilization of edible mushroom Auricularia auricula waste residue-Extraction, physicochemical properties of melanin and its antioxidant activity. Food science & nutrition. 2019. PubMed
  56. González-Bonilla A et al. Dietary Supplementation with Oyster Culinary-Medicinal Mushroom, Pleurotus ostreatus (Agaricomycetes), Reduces Visceral Fat and Hyperlipidemia in Inhabitants of a Rural Community in Mexico. International journal of medicinal mushrooms. 2022. PubMed
  57. Abrams DI et al. Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy. BMC complementary and alternative medicine. 2011. PubMed
  58. Belobrajdic DP et al. β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & function. 2024. PubMed
  59. Maheshwari G et al. Characterization of the Nutritional Composition of a Biotechnologically Produced Oyster Mushroom and its Physiological Effects in Obese Zucker Rats. Molecular nutrition & food research. 2020. PubMed
  60. Sato M et al. Long-term intake of Tamogi-take mushroom (Pleurotus cornucopiae) mitigates age-related cardiovascular dysfunction and extends healthy life expectancy. npj aging. 2025. PubMed
  61. Gong J et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Molecular nutrition & food research. 2018. PubMed
  62. Chen JT et al. Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy. 2005. PubMed
  63. Millán J et al. Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials. Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 2016. PubMed
  64. Singh DK et al. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. The Journal of pharmacology and experimental therapeutics. 2006. PubMed
  65. Castaño G et al. Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clinical drug investigation. 2003. PubMed
  66. Xiong Z et al. An overview of the bioactivity of monacolin K / lovastatin. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019. PubMed
  67. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006. EFSA journal. European Food Safety Authority. 2025. PubMed
  68. Peng D et al. Original Research: The Effects of Red Yeast Rice Supplementation on Cholesterol Levels in Adults. The American journal of nursing. 2017. PubMed
  69. Gerards MC et al. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain – a systematic review and meta-analysis. Atherosclerosis. 2015. PubMed
  70. Cicero AFG et al. Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to-Moderate Hypercholesterolemia: A Narrative Review. Nutrients. 2023. PubMed
  71. Buzzelli L et al. Alternative lipid lowering strategies: State-of-the-art review of red yeast rice. Fitoterapia. 2024. PubMed
  72. Hermans MP et al. The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia. Frontiers in pharmacology. 2023. PubMed
  73. Sun HJ et al. Deficiency of neutral cholesterol ester hydrolase 1 (NCEH1) impairs endothelial function in diet-induced diabetic mice. Cardiovascular diabetology. 2024. PubMed
  74. Park C et al. Disturbed flow induces reprogramming of endothelial cells to immune-like and foam cells under hypercholesterolaemia during atherogenesis. Cardiovascular research. 2025. PubMed
  75. Zhang S et al. Natural products: The role and mechanism in low-density lipoprotein oxidation and atherosclerosis. Phytotherapy research : PTR. 2021. PubMed
  76. Wang J et al. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice. Journal of the American Heart Association. 2017. PubMed
Zenius Labs™

AURI 25 - multi-pathway cholesterol formula

AURI 25 by Zenius Labs\u2122 is a precision formula for cholesterol control, built on clinical-trial data. It combines four complementary pathways - Auricularia auricula-judae and Pleurotus ostreatus mushroom extracts, policosanol, and monacolin K - rather than relying on a single ingredient.

Discover AURI 25

More in Cholesterol

Diet
The Cholesterol Diet: What to Eat and What to Avoid
Levels
Cholesterol Levels: What the Numbers Mean
Levels
Cholesterol Levels in mg/dL
Levels
Cholesterol Levels for Women